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Abstract – The realization of the prescription was discussed, in-
cluding the confirmation of its implementation, the otaxing, that 
is, the description of the prescription according to the adopted 
rules and the issuance of prescribed medicines, foodstuffs for 
particular nutritional purposes or medical devices by a pharma-
cist.  The obligation to inform the patient about the possibility of 
buying a cheaper equivalent of a medicine, a food for a particular 
nutritional purpose or a medical device, than those on the pre-
scription was stressed.  The pharmacy's obligation to collect in-
formation related to trade in medicines, foodstuffs for particular 
nutritional purposes and medical devices that have been written 
on prescriptions by persons authorized to do so were also charac-
terized.  
 
Key words - prescription implementation, reimbursement of re-
imbursed drugs,  summary lists, refunds, control of prescriptions. 
 
Streszczenie – Omówiono realizację recepty na co  składa się 
potwierdzenie jej realizacji, otaksowanie, czyli opisanie recepty 
według przyjętych zasad oraz wydanie przepisanych leków, 
środków spożywczych specjalnego przeznaczenia żywieniowego 
lub wyrobów medycznych przez farmaceutę. Podkreślono  
obowiązek poinformowania pacjenta o możliwości nabycia 
tańszego odpowiednika leku, środka spożywczego specjalnego 
przeznaczenia żywieniowego lub wyrobu medycznego, niż te, 
które znajdują się na recepcie. Scharakteryzowano także 
obowiązek apteki do gromadzenia informacji związanych z 
obrotem lekami, środkami spożywczymi specjalnego przez-
naczenia żywieniowego oraz wyrobami medycznymi, które zos-
tały wypisane na receptach przez osoby mające do tego uprawni-
enia. 
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I. STAGES OF COMPLETE IMPLEMENTATION 
 
 
ccording to the Regulation of the Minister of Health 
on medical prescriptions, the prescription consists of 
confirmation of its implementation, an assessment, or 
description of the prescription in accordance with the 
adopted rules and issuance of prescribed drugs, foodstuffs 
for particular nutritional use or medical devices by the 
pharmacist [ 1 ].  
 The pharmacy, in order to provide the patient with sup-
plies of medicines, special-purpose products and medical 
devices available on prescription, must conclude an agree-
ment with the National Health Fund allowing for the issu-
ance of reimbursed drugs, otherwise referred to as the pre-
scription contract.  Each pharmacy contains it separately 
for an indefinite period [ 2 ].  
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 The person who accepts the prescription for implemen-
tation, by carefully reading it should ensure that everything 
has been recorded in accordance with the accepted rules.  
If the prescription does not meet the standards, then the 
pharmacist may refuse to issue the medicines that are 
stored on it.  However, there are cases where the person 
dispensing medications can supplement or correct the 
missing information by himself.  Among the formal data 
that can be corrected, the patient's additional privilege code 
can be mentioned, which can be applied after the patient 
has shown the document confirming the specific entitle-
ment.  The second case is the lack of information in the 
field Date of completion from .  In this situation, it is as-
sumed that the symbol "X" has been entered, meaning that 
the prescription can be completed within 30 days.  The 
pharmacist may also add a certificate number for the right 
to benefits.  At the moment when the type of payment has 
not been entered or has been entered incorrectly or illegi-
bly, the pharmacist may act in two ways.  If the drug is 
available only with one payment - it may be issued in ac-
cordance with it or for the highest payment in case the drug 
has more than one payment.  When, however, the payment 
is not made and the patient has additional rights, then the 
medicines will be issued to him, taking into account the 
aforementioned entitlement.  In addition, the pharmacist 
may correct: patient data, PESEL number, passport number 
or other document certifying the identity of a foreigner and 
the doctor's license number, which can be supplemented on 
the basis of information available to the pharmacy.  Each 
of the changes should be noted on the reverse of the pre-
scription.  As for the factual shortcomings, there are sever-
al rules that guide the pharmacist in such situations.  One 
of them is the obligation to issue the lowest available dose 
of a drug if it has not been prescribed.  Another rule is the 
possibility of delivering a smaller dose than the one on the 
prescription when the dose is a multiple of the dose in 
which the medicine is delivered.  However, it should be 
remembered that the amount of active substance in a lower 
dose must correspond to the amount of active ingredient in 
the prescribed dose.  In the case when the amount of the 
drug is written on the prescription, but there is no dosage, 
the pharmacist is obliged to issue the two smallest drug 
packages listed in the reimbursement list, and if the drug 
has not been listed there, the official list of authorized 
medicines should be consulted.  However, when the doctor 
does not enter the amount of the drug and the time of use - 
the pharmacist issues one smallest pack of the drug.  When 
the prescription contains divergent information on the 
number and size of packaging, the number of dosage units 
and the dosage method on the basis of which it is not pos-
sible to clearly determine the amount of the drug, the 
pharmacy assumes that the drug should be released in the 
smallest amount prescribed by a doctor.  All prescriptions 
that have been corrected by a pharmacist must be stored 
separately.  A prescription cannot be implemented in a few 
cases, including  when the pharmacist has a reasonable 
suspicion of falsifying the prescription, when the prescrip-
tion wants to be carried out by a person under 13 years of 
age, and also if at least 6 days have passed since the day 
the prescription medicine was prepared [3].  
 In the event that the pharmacy does not have an ade-
quate number of packages of prescription medicine or if 
the patient does not have enough money to buy all medi-
cines, then the pharmacist may issue a copy of the pre-
scription.  It is carried out with full payment and only in 
the pharmacy where it was made.  The exception is very 
powerful drugs, which contain psychotropic substances or 
intoxicants - these drugs cannot be written off [ 1 ].  
  Please note that it is possible to make corrections on the 
issued prescription, but they must be made by the person 
issuing the document.  
 The corrected information must contain the signature 
and stamp of the above-mentioned  persons.  Exceptions 
are situations in which, for example, the number of the 
right to practice was illegible, the patient's age has not been 
completed, or if the patient's data has been entered incor-
rectly or illegibly, the person issuing the medicine has the 
right to make corrections to the issued prescription [ 4 ].  
 
II.  ISSUING REPRODUCTORS FOR REFUNDED 
MEDICINES 
  
 According to art.  44 of the Pharmaceutical Reim-
bursement Act, the pharmacist is obliged to inform the 
patient about the possibility of purchasing a cheaper equiv-
alent of a medicine, a food for a particular nutritional pur-
pose or a medical device, than those on the prescription.  
Such an equivalent must have the same international name, 
the same dose and pharmaceutical form and have the same 
therapeutic indication.  If the patient expects to receive 
such a replacement - the pharmacy should do it.  The ex-
ception is the situation in which the doctor placed a clear 
annotation on the prescription about the need to issue the 
original medicine, then the patient is not able to decide on 
this matter [ 2 ].  
  According to the law in force, both the prescribed medi-
cine and the medicine issued by the pharmacy must be in 
the current Notice of the Minister of Health, which con-
tains a list of reimbursed drugs [3].  





 Although the law gives the patient the opportunity to 
choose a cheaper drug, unless the doctor has indicated oth-
erwise, then generic drugs still arouse a lot of controversy.  
Patients are often afraid that they are inferior medicines or 
that they will not fulfill their therapeutic function to the 
end.  Therefore, in order to dispel any doubts, the recipient 
should consult the possibility of exchanging medicines 
with a doctor or pharmacist who will advise you on the 
proper course of action.  
  
III.  LIST COLLECTIONS, REFUNDING AND 
CONTROL OF COMPLETE 
IMPLEMENTATION 
  
 The Pharmaceutical Reimbursement Act requires phar-
macies to collect information related to trade in medicines, 
foodstuffs for particular nutritional purposes and medical 
devices that have been prescribed by persons with the au-
thority to do so.  The said information is collected and 
stored by every pharmacy in electronic form.  These mes-
sages must be forwarded to the relevant Provincial 
Branches of the Fund.  Their creation includes three stages, 
during which corrections can be made.  The entire process 
ends with the release of the pharmacy of the agreed sum-
mary statement - also in electronic form, which results in 
the completion of the settlement process.  Thus, in accord-
ance with art.  45 par.  3 above  act, the pharmacy can no 
longer bring any changes to the resulting document.  If the 
summary list is accepted, then the pharmacy must provide 
it to the appropriate Provincial Branch of the Fund also in 
writing, which is the basis for refund [ 2 ].  
 Annex No. 1 of the Ordinance of the Minister of Health 
of 14 March 2012 amending the regulation on information 
collected by pharmacies and information provided to the 
National Health Fund, contains a summary template, which 
the pharmacy must prepare and send to the NFZ.  It con-
sists of two parts.  Part A applies to a summary of prescrip-
tions for medicines, foodstuffs for particular nutritional 
uses and medical devices for persons entitled to the right of 
use under the Act on health services financed from public 
funds.  In contrast, Part B concerns those prescriptions that 
have been provided to persons benefiting from benefits 
under the provisions on coordination [ 5 , 6 ].  
 The pharmacy provides information on drug turnover in 
two dates.  The first of these applies to the period from the 
1st to the 15th of each month and the second from the 16th 
day to the end of the month.  Each statement must be de-
livered up to five business days from the day when the 
settlement period ended.  After receiving them, the Provin-
cial Department of the NHF within 5 working days carries 
out the verification of data, after which the pharmacy ad-
justs the information sent.  At the time when the pharmacy 
would not send the lists discussed - the Provincial Depart-
ment of the NFZ generates a summary list, in which no 
corrections can be made, closing a given settlement period.  
If, however, the pharmacy would like to make corrections 
in a different mode than the one specified in art.  45 par.  3 
in above  act, it must submit an appropriate application to 
the Director of the Voivodship Branch of the Fund.  After 
submitting the proper statement, the pharmacy is entitled to 
a refund of the established funding limit up to 15 days 
from its receipt.  If the Fund exceeds the set time, then the 




 Figure 1.  The course of the prescription settlement pro-
cess [for own work ] 
 
The implementation of prescriptions is subject to control 
mainly by the Fund and Provincial Pharmaceutical Inspec-
tors.  Its purpose is to assess compliance with the time lim-
its for the implementation of prescriptions, the quantity and 
size of packages issued, the proper valuation of prescrip-
tions, and whether recipes are stored in accordance with 
accepted rules.  The audit also covers the method of prepa-
ration of collective statements closing the settlement peri-
od, which constitute the basis for obtaining a refund by the 
pharmacy.  Controllers check whether the sale of medi-
cines is carried out responsibly and in accordance with the 
law.  The duty of the pharmacy is to store prescriptions for 
5 years.  They must be properly grouped, taking into ac-
count the date of the prescription, its type and the place of 





patient insurance.  Each NFZ unit must be arranged sepa-
rately [3].  
 According to art.  47 of the reimbursement act, the 
pharmacy manager or the pharmacist indicated by him 
should be present at the inspection.  Each pharmacy is also 
obliged to present prescriptions and all documents related 
to the turnover of reimbursed drugs.  Prescriptions may be 
made available to the inspecting authority no sooner than 
after the end of the settlement period.  A request for access 
to documentation must always be confirmed in writing.  A 
report is prepared for each control, which contains infor-
mation on the degree of implementation of the contract 
with the Fund.  On its basis, the Provincial Department of 
the National Health Fund prepares recommendations that 
oblige the pharmacy to remove the irregularities.  The NFZ 
branch must be informed about the measures taken within 
14 days of receiving the recommendations.  From the rec-
ommendations received, the pharmacy has the right to 
submit a complaint within 7 days.  His lodging suspends 
the implementation of post-control recommendations until 
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